Achieving a New Balance: Neuromodulation with PoNS™ (Portable Neuromodulation Stimulator) for Chronic Balance Deficit Due to Mild-to-Moderate Traumatic Brain Injury will provide details that are relevant to the current disease and treatment landscapes for patients with chronic balance and gait deficits associated with mild-to-moderate traumatic brain injury (mmTBI). Randomized clinical trial data will be presented on how PoNS™ affects balance, gait, and other factors in participants with chronic balance deficit and other symptoms due to mmTBI.
An estimated 69 million people worldwide sustain a TBI each year. Despite the current standard of care, instability or imbalance can persist after mmTBI, which often results in a significant negative impact on patients’ functional status and quality of life. Program faculty will describe how noninvasive translingual neurostimulation of cranial nerves is a novel treatment option for these patients. The Portable Neuromodulation Stimulator (PoNS™) is a tongue-based neuromodulation treatment that involves noninvasive, electrical stimulation on the tongue through an array of 143 gold-plated electrodes.
An interactive audience and faculty panel discussion will be held at the end of the symposium to discuss opportunities and challenges in caring for this affected patient population.
PoNS™ is a licensed medical device in Canada that is approved as an adjunct to physical therapy for chronic balance deficits in patients with mmTBI. PoNS™ is an investigational device under review for clearance by the US Food and Drug Administation and by an EU notified body; PoNS™ is not commercially available in the United States, European Union, or Australia.